IShares Nasdaq (Switzerland) Profile
| BTEC Etf | USD 5.88 0.01 0.17% |
Performance0 of 100
| Odds Of DistressLess than 9
|
IShares Nasdaq is selling for under 5.88 as of the 25th of April 2024; that is 0.17 percent up since the beginning of the trading day. The etf's lowest day price was 5.83. IShares Nasdaq has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for iShares Nasdaq Biotechnology are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of March 2024 and ending today, the 25th of April 2024. Click here to learn more.
The Fund seeks to track the performance of the NASDAQ Biotechnology Index . ISh Nasdaq is traded on Switzerland Exchange in Switzerland. More on iShares Nasdaq Biotechnology
IShares Etf Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. IShares Nasdaq's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding IShares Nasdaq or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | null, BlackRock Asset Management Ireland - ETF (View all Sectors) |
| As Of Date | 31st of May 2020 |
iShares Nasdaq Biotechnology [BTEC] is traded in Switzerland and was established 2017-10-19. The fund is listed under null category and is part of BlackRock Asset Management Ireland - ETF family. iShares Nasdaq Biote currently have 219 M in assets under management (AUM). , while the total return for the last year was 30.59%.
Check IShares Nasdaq Probability Of Bankruptcy
iShares Nasdaq Biote Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. IShares Nasdaq market risk premium is the additional return an investor will receive from holding IShares Nasdaq long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in IShares Nasdaq. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although IShares Nasdaq's alpha and beta are two of the key measurements used to evaluate IShares Nasdaq's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.6664 | |||
| Standard Deviation | 0.8732 | |||
| Variance | 0.7625 | |||
| Risk Adjusted Performance | (0.09) |
iShares Nasdaq Biote Technical Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. iShares Nasdaq Biote Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe IShares Nasdaq price patterns.
IShares Nasdaq Against Markets
Picking the right benchmark for IShares Nasdaq etf is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in IShares Nasdaq etf price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for IShares Nasdaq is critical whether you are bullish or bearish towards iShares Nasdaq Biotechnology at a given time. Please also check how IShares Nasdaq's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in IShares Nasdaq without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
How to buy IShares Etf?
Before investing in IShares Nasdaq, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in IShares Nasdaq. To buy IShares Nasdaq etf, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of IShares Nasdaq. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase IShares Nasdaq etf. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located iShares Nasdaq Biotechnology etf in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased iShares Nasdaq Biotechnology etf, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the etf
It's important to note that investing in stocks, such as iShares Nasdaq Biotechnology, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in etf prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in iShares Nasdaq Biotechnology?
The danger of trading iShares Nasdaq Biotechnology is mainly related to its market volatility and ETF specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of IShares Nasdaq is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than IShares Nasdaq. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile iShares Nasdaq Biote is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in iShares Nasdaq Biotechnology. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.